Deletion of FRβ+ TAMs leads to a tumor microenvironment enriched in pro-inflammatory monocytes, followed by enhanced influx of endogenous tumor-specific CD8+ T cells which delays tumor progression and prolongs mouse survival. Here, CD8A is linked to neoplasm.